Clinical trial
Credit-AF: A Randomized Control Study of Driver Ablation Combined With Circumferential Pulmonary Vein Isolation Versus Stepwise Ablation as a Treatment in Patients With Persistent Atrial Fibrillation.
NCT04489004 is registered in ClinicalTrials.gov with Shanghai Chest Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Credit-AF: A Randomized Control Study of Driver Ablation Combined With Circumferential Pulmonary Vein Isolation Versus Stepwise Ablation as a Treatment in Patients With Persistent Atrial Fibrillation.
- Lead sponsor
- Shanghai Chest Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2020
- Completion date
- December 1, 2022
- Enrollment
- 1,298 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, persistent